Sunflower Therapeutics
PrivateLast Round
Grant
Sep 3, 2025
Total Funding Raised
$22.46M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Sunflower Therapeutics operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in September 2025.
Sunflower Therapeutics is a biotechnology company that develops next-generation, automated, and fully-integrated protein manufacturing solutions to simplify the process from discovery to full-scale biomanufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Smart Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sunflower Therapeutics Comparables
Compare Sunflower Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioscibex | 77% | |
| Centillion Biosciences Inc. | 75% | |
| Danaher | 71% |
For institutional investors. Book with your work email.
Sunflower Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 3, 2025 | ||||
| SAFE | Dec 3, 2024 | ||||
| Grant | Jan 18, 2023 | ||||
| VC Round | Aug 17, 2021 | ||||
| Grant | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sunflower Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerald Development Managers | SAFE |
| National Institute of Allergy and Infectious Diseases | Grant |
| Alwyn Capital | SAFE |
| NIH RADx | Grant |
| Roivant Social Ventures | VC Round |
| Gates Foundation | Grant |
| U.S. Government | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors grew 69% MoM.
- Feb 12, 2026
Partnered with MATSUBO Corporation for Japanese market expansion.
For institutional investors. Book with your work email.
Sunflower Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sunflower Therapeutics's valuation, stock price, and market status.
Is Sunflower Therapeutics a public or private company?
Sunflower Therapeutics is a private company.
What is the current stock price of Sunflower Therapeutics?
Sunflower Therapeutics is a private company, so its shares have no public market price. Caplight tracks Sunflower Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sunflower Therapeutics worth (valuation)?
Valuation information for Sunflower Therapeutics is not publicly available.
Can I buy Sunflower Therapeutics stock?
Sunflower Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sunflower Therapeutics's last funding round?
Sunflower Therapeutics's most recent funding round was Grant on September 3, 2025.
Who are the main investors in Sunflower Therapeutics?
Key investors in Sunflower Therapeutics include Roivant Social Ventures.
Will Sunflower Therapeutics IPO soon?
No public IPO plans have been announced for Sunflower Therapeutics.
How can I track Sunflower Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Sunflower Therapeutics's shares on secondary markets.